The AGs from California, Florida, Hawaii, Mississippi and Washington filed a supplemental statement to the U.S. District Court for the District of Columbia June 28. In the statement, the AGs said a review of testimony and court documents “affirmed our belief that the horizontal aspects of the merger presented anticompetitive issues and that the proposed [Medicare Part D] divestiture provides an effective and appropriate remedy for the antitrust violations alleged in the complaint. Therefore, plaintiff states reaffirm our support for approval of the proposed final judgment by the court as being in the public interest.”
The states also asked to address the court for 10 minutes during a hearing for oral arguments scheduled for July 17.
In June, U.S. District Judge Richard Leon wrapped up two days of hearings on CVS Health’s $69 billion takeover of Aetna and scheduled more oral arguments on the deal in July. He has questioned whether the DOJ’s deal to address any anticompetitive concerns with the merger is sufficient.
More articles on payers:
10 updates on UnitedHealth Group
16 payer exec moves in 2019
Christiana Care, Highmark Medicaid strike value-based partnership
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
